
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 12.54 | 21.5463917526 | 58.2 | 70.74 | 58.2 | 795844 | 65.87951301 | CS |
4 | 2.45 | 3.58764094304 | 68.29 | 70.74 | 58.2 | 625488 | 64.38023127 | CS |
12 | -14.36 | -16.8742655699 | 85.1 | 87.08 | 58.2 | 646904 | 69.14647327 | CS |
26 | -0.73 | -1.0214075836 | 71.47 | 107.3699 | 58.2 | 588637 | 78.3885789 | CS |
52 | -2.94 | -3.99022801303 | 73.68 | 107.3699 | 47.88 | 522134 | 69.67187635 | CS |
156 | 52.58 | 289.537444934 | 18.16 | 107.3699 | 6.035 | 503266 | 46.39585522 | CS |
260 | 51.74 | 272.315789474 | 19 | 107.3699 | 6.035 | 494798 | 46.12904434 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales